Advertisement

Nail psoriasis severity index: a useful tool for evaluation of nail psoriasis

      Abstract

      The Nail Psoriasis Severity Index (NAPSI) is a numeric, reproducible, objective, simple tool for evaluation of nail psoriasis. This scale is used to evaluate the severity of nail bed psoriasis and nail matrix psoriasis by area of involvement in the nail unit. The NAPSI will be useful during clinical trials for evaluating response to treatment of psoriatic nails. The scale is reproducible, and because there are few data points, statistical analysis is simplified.
      To read this article in full you will need to make a payment
      AAD Member Login
      AAD Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Zachariae R.
        • Zachariae H.
        • Blomqvist K.
        • Davidsson S.
        • Molin L.
        • Mork C.
        • et al.
        Quality of life in 6497 Nordic patients with psoriasis.
        Br J Dermatol. 2002; 146: 1006-1016
        • De Arruda L.H.
        • De Moraes A.P.
        The impact of psoriasis on quality of life.
        Br J Dermatol. 2001; 144: 33-36
        • Kreuger G.
        • Koo J.
        • Lebwohl M.
        • Menter A.
        • Stern R.S.
        • Rolstad T.
        • et al.
        The impact of psoriasis on quality of life.
        Arch Dermatol. 2001; 137: 280-284
        • De Jong E.M.
        • Seegers B.A.
        • Gulinck M.K.
        • Boezeman J.B.
        • van de Kekhof P.C.
        Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients.
        Dermatology. 1996; 193: 300-303
        • Scher R.K.
        • Stiller M.
        • Zhu Y.I.
        Tazarotene 0.1% gel in the treatment of fingernail psoriasis.
        Cutis. 2001; 68: 355-358
        • Schissel D.J.
        • Elston D.M.
        Topical 5-fluorouracil treatment for psoriatic trachyonychia.
        Cutis. 1998; 62: 27-28
        • Yananoto T.
        • Katayama I.
        • Nishioka K.
        Topical anthralin therapy for refractory nail psoriasis.
        J Dermatol. 1998; 25: 231-233
        • Mahrle G.
        • Schulze H.J.
        • Farber L.
        • Weidinger G.
        • Steigleder G.K.
        Low-dose short-term cyclosporine versus etretinate in psoriasis.
        J Am Acad Dermatol. 1995; 32: 78-88
        • Kwang T.Y.
        • Nee T.S.
        • Seng K.T.
        A therapeutic study of nail psoriasis using electron beams.
        Acta Derm Venereol. 1995; 75: 90
        • Arnold W.P.
        • Gerritsen M.J.
        • van de Kerkhof P.C.
        Response of nail psoriasis to cyclosporin.
        Br J Dermatol. 1993; 129: 750-751
        • Yu R.C.
        • King C.M.
        A double-blind study of superficial radiotherapy in psoriatic nail dystrophy.
        Acta Derm Venereol. 1992; 72: 134-136
        • Tosti A.
        • Guerra L.
        • Bardazzi F.
        • Lanzarini M.
        Topical ciclosporin in nail psoriasis.
        Dermatologica. 1990; 180: 110
        • Lindelof B.
        Psoriasis of the nails treated with grenz rays.
        Acta Derm Venereol. 1989; 69: 80-82
        • Marx J.L.
        • Scher R.K.
        Response of psoriatic nails to oral photochemotherapy.
        Arch Dermatol. 1980; 116: 1023-1024
        • Tosti A.
        • Piraccini B.M.
        • Cameli N.
        • Kokely F.
        • Plozzer C.
        • Cannata G.E.
        • et al.
        Calcipotriol ointment in nail psoriasis.
        Br J Dermatol. 1998; 139: 655-659
        • Pierard G.E.
        • Pierard-Franchmimont C.
        Dynamics of psoriatic trachyonychia during low-dose cyclosporin A treatment: a pilot study on onychochronobiology using optical profilometry.
        Der-matology. 1996; 192: 116-119
        • de Jong E.M.
        • Menke H.E.
        • van Praag M.C.
        • van De Kerkhof P.C.
        Dystrophic psoriatic fingernails treated with 1% 5-fluorouracil in a nail penetration-enhancing vehicle.
        Dermatology. 1999; 199: 313-318